These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6893692)

  • 1. Double-blind controlled trial of molsidomine in hypertension.
    Milei J; Vazquez A; Lemus J
    Eur J Clin Pharmacol; 1980 Oct; 18(3):231-5. PubMed ID: 6893692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute double blind trial of a new anti-anginal drug: molsidomine.
    Guerchicoff S; Vazquez A; Kunik H; Drajer S; Díaz F
    Eur J Clin Pharmacol; 1978 Jun; 13(4):247-50. PubMed ID: 352706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of molsidomine on haemodynamics at rest and on exercise in patients who have coronary heart disease (author's transl)].
    Niehues B; Krimmel W; Hombach V; Tauchert M; Behrenbeck DW; Hilger HH
    Dtsch Med Wochenschr; 1978 May; 103(20):853-6. PubMed ID: 648365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.
    Aptecar M; Otero y Garzon CA; Vasquez A; Varini S; Collia L; Esteguy A; Caruso S
    Am Heart J; 1981 Apr; 101(4):369-73. PubMed ID: 6894215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
    Messin R; Demaret B; Denolin H
    Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
    Baudry C
    Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The normalizing effect of ECG in exercise tolerance tests under molsidomine in different dosages (author's transl].
    Jansen E; Klepzig H
    Med Klin; 1978 Jun; 73(26):983-6. PubMed ID: 672755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ischemic effects of molsidomine in an experimental model of coronary artery stenosis.
    Nitz RE; Mogilev AM; Göbel H
    Adv Myocardiol; 1983; 4():595-604. PubMed ID: 6687948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a new antihypertensive vasodilating agent PR--G 138 Cl.
    Vos J; Dorhout Mees EJ
    Br J Clin Pharmacol; 1979 Aug; 8(2):155-62. PubMed ID: 385024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
    Mindlin de Aptecar FR; Vazquez A; Aptecar M
    Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.